MA45768A - Procédé pour la préparation de compositions d'immunoglobulines - Google Patents
Procédé pour la préparation de compositions d'immunoglobulinesInfo
- Publication number
- MA45768A MA45768A MA045768A MA45768A MA45768A MA 45768 A MA45768 A MA 45768A MA 045768 A MA045768 A MA 045768A MA 45768 A MA45768 A MA 45768A MA 45768 A MA45768 A MA 45768A
- Authority
- MA
- Morocco
- Prior art keywords
- preparation
- immunoglobulin compositions
- immunoglobulin
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/30—Extraction; Separation; Purification by precipitation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16181493.4A EP3275897A1 (fr) | 2016-07-27 | 2016-07-27 | Procédé de préparation de compositions d'immunoglobuline |
Publications (1)
Publication Number | Publication Date |
---|---|
MA45768A true MA45768A (fr) | 2019-06-05 |
Family
ID=56555240
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA045768A MA45768A (fr) | 2016-07-27 | 2017-07-26 | Procédé pour la préparation de compositions d'immunoglobulines |
Country Status (10)
Country | Link |
---|---|
US (2) | US11325964B2 (fr) |
EP (2) | EP3275897A1 (fr) |
JP (1) | JP7073333B2 (fr) |
CN (1) | CN109641950B (fr) |
AU (1) | AU2017302006B2 (fr) |
BR (1) | BR112019000736A2 (fr) |
CA (1) | CA3031462A1 (fr) |
EA (1) | EA201990392A1 (fr) |
MA (1) | MA45768A (fr) |
WO (1) | WO2018019898A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160257754A1 (en) | 2013-10-16 | 2016-09-08 | Momenta Pharmaceuticals Inc. | Sialylated glycoproteins |
CN109575129B (zh) * | 2018-12-29 | 2022-04-26 | 贵州泰邦生物制品有限公司 | 一种静注人免疫球蛋白的制备工艺 |
US11732004B2 (en) * | 2020-04-10 | 2023-08-22 | Plasma Technologies, Llc | Compositions and methods for simplified high efficiency isolation of proteins |
WO2022146856A1 (fr) * | 2020-12-28 | 2022-07-07 | Plasma Technologies, Llc | Systèmes et procédés d'isolement pour l'isolement à l'échelle de procédé de l'immunoglobuline g |
MX2024001187A (es) * | 2021-07-29 | 2024-02-27 | Csl Behring Ag | Metodo para purificar inmunoglobulina g y usos de la misma. |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4136094A (en) | 1977-08-31 | 1979-01-23 | The Regents Of The University Of Minnesota | Preparation of intravenous human and animal gamma globulins and isolation of albumin |
US4296027A (en) | 1977-08-31 | 1981-10-20 | The Regents Of The University Of Minnesota | Pure intravenous human and animal gamma globulins |
DE2901822A1 (de) | 1979-01-18 | 1980-07-31 | Biotest Serum Institut Gmbh | Verfahren zur herstellung einer fuer die intravenoese applikation geeigneten immunglobulinloesung, die igm in ankonzentrierter form enthaelt |
SU1137098A1 (ru) * | 1983-07-21 | 1985-01-30 | Московская ветеринарная академия им.К.И.Скрябина | Способ выделени пропердина из сыворотки крови |
IL90281A (en) | 1988-06-06 | 1994-10-07 | Miles Inc | Preparations containing MGI antibodies |
DE3825429C2 (de) | 1988-07-27 | 1994-02-10 | Biotest Pharma Gmbh | Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt |
DE3927112C1 (fr) | 1989-08-17 | 1990-10-25 | Biotest Pharma Gmbh, 6072 Dreieich, De | |
DE3927111C3 (de) | 1989-08-17 | 1994-09-01 | Biotest Pharma Gmbh | Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate |
ATE122054T1 (de) | 1990-03-22 | 1995-05-15 | Biotest Pharma Gmbh | Verfahren zur herstellung eines intravenös verträglichen immunglobulin-g-präparates. |
US5256771A (en) | 1990-04-03 | 1993-10-26 | Miles Inc. | Heat treatment of IgM-containing immunoglobulins to eliminate non-specific complement activation |
FI952196A0 (fi) | 1995-05-08 | 1995-05-08 | Suomen Punainen Risti Veripalv | Framstaellning av immunoglobulin |
TW491855B (en) * | 1996-08-07 | 2002-06-21 | Csl Ltd | Purification of immunoglobulins |
JP2001513576A (ja) * | 1997-08-26 | 2001-09-04 | グリアテック インコーポレイテッド | 側副経路を介する補体活性化を阻害するためのプロセス |
US5854051A (en) | 1997-09-15 | 1998-12-29 | Heska Corporation | Parasitic helminth asparaginase proteins, nucleic acid molecules, and uses thereof |
DK2270044T3 (en) * | 1998-06-09 | 2015-01-26 | Csl Behring Ag | Liquid immunoglobulin G (IgG) product |
FR2824568B1 (fr) * | 2001-05-11 | 2004-04-09 | Lab Francais Du Fractionnement | Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique |
US6593744B2 (en) * | 2001-11-20 | 2003-07-15 | Koninklijke Philips Electronics, N.V. | Multi-channel RF cable trap for magnetic resonance apparatus |
SG176256A1 (en) * | 2009-05-27 | 2012-01-30 | Baxter Int | A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use |
IT1397061B1 (it) | 2009-12-28 | 2012-12-28 | Kedrion Spa | Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale. |
GB201006753D0 (en) | 2010-04-22 | 2010-06-09 | Biotest Ag | Process for preparing an immunolobulin composition |
AU2010202125B1 (en) * | 2010-05-26 | 2010-09-02 | Takeda Pharmaceutical Company Limited | A method to produce an immunoglobulin preparation with improved yield |
IL212911A0 (en) * | 2011-05-16 | 2011-07-31 | Omrix Biopharmaceuticals Ltd | Immunoglobulin reduced in thrombogenic contaminants and preparation thereof |
WO2013006449A2 (fr) * | 2011-07-01 | 2013-01-10 | The Trustees Of The University Of Pennsylvania | Anticorps anti-properdine et leurs utilisations |
MX349005B (es) | 2011-08-26 | 2017-07-06 | Baxalta Inc | Metodo para reducir el potencial tromboembolico de una composicion de inmunoglobulina derivada de plasma. |
SG10201701224UA (en) * | 2012-03-12 | 2017-04-27 | Merck Patent Gmbh | Removal of protein aggregates from biopharmaceutical preparations in a flowthrough mode |
AU2013203043B2 (en) * | 2013-03-15 | 2016-10-06 | Takeda Pharmaceutical Company Limited | Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs |
DK3016976T3 (da) * | 2013-07-01 | 2020-12-07 | Csl Behring Ag | Proces |
FR3018450B1 (fr) | 2014-03-11 | 2016-04-15 | Lab Francais Du Fractionnement | Procede de preparation de proteines plasmatiques humaines |
CN106414476B (zh) * | 2014-03-11 | 2019-12-31 | 株式会社绿十字控股 | 用于纯化免疫球蛋白的方法 |
CN104402993B (zh) * | 2014-11-28 | 2017-01-04 | 贵州泰邦生物制品有限公司 | 一种制备静注人免疫球蛋白的方法 |
-
2016
- 2016-07-27 EP EP16181493.4A patent/EP3275897A1/fr not_active Withdrawn
-
2017
- 2017-07-26 WO PCT/EP2017/068914 patent/WO2018019898A1/fr unknown
- 2017-07-26 EA EA201990392A patent/EA201990392A1/ru unknown
- 2017-07-26 BR BR112019000736-9A patent/BR112019000736A2/pt unknown
- 2017-07-26 JP JP2019504003A patent/JP7073333B2/ja active Active
- 2017-07-26 CN CN201780052839.1A patent/CN109641950B/zh active Active
- 2017-07-26 CA CA3031462A patent/CA3031462A1/fr active Pending
- 2017-07-26 EP EP17742268.0A patent/EP3491018A1/fr active Pending
- 2017-07-26 AU AU2017302006A patent/AU2017302006B2/en active Active
- 2017-07-26 MA MA045768A patent/MA45768A/fr unknown
- 2017-07-26 US US16/320,900 patent/US11325964B2/en active Active
-
2022
- 2022-04-08 US US17/716,674 patent/US20220227841A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US11325964B2 (en) | 2022-05-10 |
CA3031462A1 (fr) | 2018-02-01 |
CN109641950A (zh) | 2019-04-16 |
JP7073333B2 (ja) | 2022-05-23 |
EP3275897A1 (fr) | 2018-01-31 |
AU2017302006B2 (en) | 2024-07-25 |
JP2019525933A (ja) | 2019-09-12 |
CN109641950B (zh) | 2023-06-02 |
EP3491018A1 (fr) | 2019-06-05 |
EA201990392A1 (ru) | 2019-07-31 |
WO2018019898A1 (fr) | 2018-02-01 |
US20190161533A1 (en) | 2019-05-30 |
US20220227841A1 (en) | 2022-07-21 |
AU2017302006A1 (en) | 2019-01-24 |
BR112019000736A2 (pt) | 2019-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA45768A (fr) | Procédé pour la préparation de compositions d'immunoglobulines | |
MA51988A (fr) | Procédé pour la préparation de composés utiles à traiter l'amyotrophie spinale | |
MA55629A (fr) | Compositions d'anticorps pour le traitement de tumeurs | |
MA52665A (fr) | Procédé d'amélioration de l'expression de l'hémoglobine foetale | |
MA44083A (fr) | Composés de biarylmonobactame pour le traitement d'infections bactériennes | |
MA44873A (fr) | Composition pour le traitement de la dégénérescence maculaire liée a l'âge exsudative | |
MA49279A (fr) | Compositions d'anticorps optimisées pour le traitement de troubles oculaires | |
MA49752A (fr) | Procédés de préparation de composés de pyrrolidine | |
MA43872A (fr) | Procédé de traitement d'une glomérulopathie à c3 | |
MA41200B1 (fr) | Procédé pour la préparation d'un composé diarylthiohydantoïne | |
MA45155A (fr) | Procédés de préparation d'oligomères morpholino de phosphorodiamidate | |
MA44875A (fr) | Compositions pour le traitement de troubles acido-basiques | |
MA52906A (fr) | Procédé de préparation d'amg 416 | |
MA49700A (fr) | Procédé amélioré pour la préparation de dérivés d'aminopyrimidine | |
MA44737A (fr) | Compositions pour le traitement de troubles liés à l'hyperkératose | |
MA45183A (fr) | Procédés de préparation d'oligomères morpholino de phosphorodiamidate | |
MA49775A (fr) | Procédés de préparation d'oligomères morpholino de phosphorodiamidate | |
MA53370A (fr) | Procédé et intermédiaires pour la préparation de bilastine | |
MA42423A (fr) | Procédé de préparation d'un revêtement | |
MA55917A (fr) | Procédé de cristallisation de dérivés d'aripiprazole dans des formulations à libération prolongée pour le traitement de la schizophrénie | |
MA49472A (fr) | Procédé de préparation d'intermédiaire de dérivé de 4-méthoxypyrrole | |
MA45552A (fr) | Compositions destinées au traitement de l'amylose | |
MA42497A (fr) | Procédés et compositions pour la régulation sélective de l'expression protéique | |
MA46431A (fr) | Composés et procédés pour réduire l'expression de tau | |
MA51870A (fr) | Procédé pour la préparation de composés coupleurs de médicaments |